Helicobacter and Digestive Malignancies

Helicobacter

Volumn 11, Issue SUPPL.1, 2006, Pages 32-35

  Starzyñska, Teresa ^a   Malfertheiner, Peter ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Gastric malignancy; Helicobacter; Pathogenesis; Prevention; Risk factors

Indexed keywords

ANIMAL; C57BL MOUSE; CAT; HELICOBACTER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIOLOGY; MOUSE; PATHOGENICITY; REVIEW; RISK FACTOR; STOMACH TUMOR; TUMOR CELL LINE;

ANIMALS; CATS; CELL LINE, TUMOR; HELICOBACTER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICE; MICE, INBRED C57BL; RISK FACTORS; STOMACH NEOPLASMS;

EID: 36649035994     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1478-405X.2006.00431.x     Document Type: Article

References (34)

1. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-44.
2. Ratajczak MZ, Kucia M, Dabrowska H, Wanzeck J, Reca R, Ratajczak J. Emerging concept of cancer as a stem cell disorder. Central Eur J Biol 2006;1:73-87.
3. Houghton J, Stoicov C, Roger A, Carbon J, Li H, Cai X, Fox J, Goldering J, Wang T. Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568-71.
4. Cai X, Carlson J, Stoicov C, Li H, Wang T, Houghton J. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 2005;128:1937-52.
5. Houghton J, Wang T. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancer. Gastroenterology 2005;128:1567-78.
6. + stem cells identified in adult bone marrow. Leukemia 2006;20:857-69.
7. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. NF-κ B functions as a tumour promotor in inflammation-associated cancer. Nature 2004;431:461-6.
8. Saganuma M, Kuzuhara T, Yamaguchi K, Fujiki H. Cancerogenic role of tumour necrosis factor-alfa-inducing protein of Helicobacter pylori in human stomach. J Bioch Mol Biol; 2006;39:1-8.
9. Saganuma M, Kurusu M, Suzuki K, Nishizono A, Murakami K, Fujioka T, Fujiki H. New tumour necrosis factor-alfa-inducing protein released from Helicobacter pylori for gastric cancer progression. J Cancer Res Clin Oncol 2005;131:305-13.
10. Franco AT, Israel DA, Washington MK, et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci USA 2005;102:10646-51.
11. Palli D, Saieva C, Luzzi I, et al. Interleukin 1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am J Gastroenterol 2005;100:1941-8.
12. Sicinschi LA, Lopez-Carrillo L, Camargo MC, Correa P, Sierra RA, Henry RR, hen J, Zabaleta J, Piazuelo MB, Schneider BG. Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA-positive infection and polymorphisms in interleukin 1 and 10 genes. Int J Cancer 2006;118:649-57.
13. Zang WH, Wang XL, Zhou J, An LZ, Xie XD. Association of interleukin 1B (IL-1B) gene polymorphisms with risk of gastric cancer in Chinese population. Cytokine 2005;30:378-81.
14. Ruzzo A, Graziano F, Pzzagali F, et al. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter -negative gastric cancer of intestinal and diffuse histotype. Ann Oncol 2005;16:887-92.
15. Sakuma K, Uozaki H, Chong JM, Hironaka M, SudoM, Ushiku T, Nagai H, Fukayama M. Cancer risk to the gastric corpus in Japanese, its correlation with interleukin 1Beta gene polymorphism (+3953) and Ebstein-Barr virus infection. Int J Cancer 2005;115:93-7.
16. Perri F, Piepoli A, Bonvicini C, et al. Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine 2005;30:293-302.
17. Zambon CF, Basso D, Navaglia F, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interaction influence outcome. Cytokine 2005;29:141-52.
18. Kim N, Cho SI, Yim JY, Kim JM, Lee DH, Park JH, Kim JS, Jung HC, Song IS. The effect of genetic polymorphisms of IL-1 and TNF-α on Helicobacter pylori -induced gastroduodenal diseases in Korea. Helicobacter 2006;11:105-12.
19. Starzyñska T, Ferenc K, Wex T, Kahne T, Lubiñski J, Ławniczak M, Marlicz K, Malfertheiner P. The association between the interleukin 1 polymorphisms and gastric cancer risk depends on the family history of gastric carcinoma in the study population. Am J Gastroenterol 2006;101:248-54.
20. Chang YW, Jang JY, Kim NH et al. Interleukin 1B (IL-1B) polymorphisms and gastric mucosal level of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer 2005;114:465-71.
21. Hu S, Song Q-B, Yao P-F, Hu Q-L, Hu P-J, Zeng Z-R, Pang R-P. No relationship between IL-1B gene polymorphism and gastric acid secretion in younger healthy volunteers. World J Gastroenterol 2005;11:6549-53.
22. Lee JY, Kim HY, Kim KH, Kim SM, Jang MK, Park JY, Lee JH, Kim JH, Yoo JY. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett 2005;225:207-14.
23. Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, Koike T, Sekine H, Ohara S, Shimosegawa T. The polymorphism interleukin 8-251A/T influences the susceptibility of Helicobacter pylori -related diseases in the Japanese population. Gut 2005;54:330-5.
24. Savage SA, Hou L, Lissowska J, Chow W.-H, Zatonski W, Chanock SJ, Yeager M. Interleukin 8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev 2006;15:589-91.
25. Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphism in inflammation-related genes and risk of gastric cancer. Cancer Causes Control 2006;17:117-25.
26. Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, Hishida A, Ishizaki T. Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Aliment Pharmacol Ther 2005;22:1033-40.
27. Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Megraud F, Xiao SD, Sugano K, Nyren O and Lejondal H. pylori gastric cancer task force. Helicobacter pylori eradication has the potential to prevent gastric cancer. A state-of-the-art critique. Am J Gastroenterol 2005;100:2100-15.
28. Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 2006;11:75-80.
29. Fujimori S, Kishida T, Kobaiashi T, et al. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol 2005;40:887-93.
30. Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, Kato H, Uchida M, Yoshikawa T, Inui A. Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer 2005;117:1058-9.
31. Grahn N, Hmani-Aifa M, Fransen K, Soderkvist P, Monstein HJ. Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplification and pyrosequencing analysis. J Med Microbiol 2005;54:1031-5.
32. Wu X-Z, Chen D. Helicobacter pylori and hepatocellular carcinoma: correlated or uncorrelated? J Hepatol Gastroenterol 2006;21:345-7.
33. Rocha M, Avenaud P, Menard A, Le Bail B, Balabaud C, Bioulac-Sage P, de Magalhaes Queiroz OM, Megraud F. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 2005;54:396-401.
34. Zahn Y, Fan XG, Chen R, Xiao ZQ, Feng XP, Tian XF, Chen ZH. Comparative proteome analysis of untreated and Helicobacter pylori-treated HepG2. World J Gastroenterol 2005;11:3485-9.